Global Neo-Endorphin Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Neo-Endorphin Market Research Report 2024
According to MRAResearch’s new survey, global Neo-Endorphin market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Neo-endorphin is a new member of the endorphin family about which relatively little is known. According to existing knowledge, Neo-endorphin may be a biochemically synthesized hormone secreted by the pituitary gland, which binds to opioid receptors on the cell surface and regulates the opening and closing of potassium, calcium and other ion channels in the cell membrane. Changes the resting potential of cells, thus exerting effects similar to morphine, including analgesic, euphoria, narrowing pupils, regulating body temperature, etc.
Under stress conditions of the body, such as exercise, painful stimulation, major blows to the body, etc., the release of Neo-endorphins can protect the body. In addition, activities such as jogging and eating spicy food may also promote the release of Neo-endorphins. However, excessive levels of Neo-endorphins may also have adverse health effects, including autism, depression, insomnia, frigidity, etc.
In summary, Neo-endorphin is a new member of endorphins with potential therapeutic applications, and more research is needed to deeply understand its biochemical properties, physiological effects, and pharmacological properties to provide a theory for the development of new therapeutic methods. Base.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Neo-Endorphin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
Segment by Type
α-Neo-Endorphin
β-Neo-Endorphin
Scientific Research
Medical
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Neo-Endorphin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Neo-endorphin is a new member of the endorphin family about which relatively little is known. According to existing knowledge, Neo-endorphin may be a biochemically synthesized hormone secreted by the pituitary gland, which binds to opioid receptors on the cell surface and regulates the opening and closing of potassium, calcium and other ion channels in the cell membrane. Changes the resting potential of cells, thus exerting effects similar to morphine, including analgesic, euphoria, narrowing pupils, regulating body temperature, etc.
Under stress conditions of the body, such as exercise, painful stimulation, major blows to the body, etc., the release of Neo-endorphins can protect the body. In addition, activities such as jogging and eating spicy food may also promote the release of Neo-endorphins. However, excessive levels of Neo-endorphins may also have adverse health effects, including autism, depression, insomnia, frigidity, etc.
In summary, Neo-endorphin is a new member of endorphins with potential therapeutic applications, and more research is needed to deeply understand its biochemical properties, physiological effects, and pharmacological properties to provide a theory for the development of new therapeutic methods. Base.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Neo-Endorphin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
Segment by Type
α-Neo-Endorphin
β-Neo-Endorphin
Segment by Application
Scientific Research
Medical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Neo-Endorphin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices